Knut Håkon Hole - Concepedia

Author

Knut Håkon Hole

Oslo University Hospital ORCID

Also Known As

Hole, Knut, K H Hole, K. H. Hole, K. Hole, K.H. Hole, Knut H Hole, Knut H. Hole, Knut Hakon Hole, Knut Håkon Hole

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Oslo University Hospital University of Oslo Akershus University Hospital Norwegian University of Science and Technology Norwegian Cancer Society

About

Knut Håkon Hole is an author at Oslo University Hospital specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	625
2	Health Sciences	6	6	464
3	Engineering	1	1	38
4	Cell Biology	1	1	56
5	Immunology	1	1	95

Knut Håkon Hole

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
The tumour hypoxia marker pimonidazole reflects a transcriptional programme associated with aggressive prostate cancer Harald Bull Ragnum, Ljiljana Vlatkovic, A. Kathrine Lie, British Journal of Cancer	2014	220
Neoadjuvant chemotherapy in breast cancer-response evaluation and prediction of response to treatment using dynamic contrast-enhanced and diffusion-weighted MR imaging Anne Fangberget, Line Brennhaug Nilsen, Knut Håkon Hole, European Radiology	2010	146
Radiological and clinical assessment of long-term brain tumour survivors after radiotherapy Tom Børge Johannesen, Hans H. Lien, Knut Håkon Hole, Radiotherapy and Oncology Adaptive RadiotherapyNeuro-oncologyRadiation TherapyGliomaMedicine	2003	141
Vorinostat, a histone deacetylase inhibitor, combined with pelvic palliative radiotherapy for gastrointestinal carcinoma: the Pelvic Radiation and Vorinostat (PRAVO) phase 1 study Anne Hansen Ree, Svein Dueland, Sigurd Folkvord, The Lancet Oncology Radiation TherapyHistone Deacetylase InhibitorPelvic RadiationMedicineGastrointestinal Oncology	2010	122
Phase I/IIa clinical trial of a novel hTERT peptide vaccine in men with metastatic hormone-naive prostate cancer Wolfgang Lilleby, Gustav Gaudernack, Paal Brunsvig, Cancer Immunology Immunotherapy VaccinationUrologyGenitourinary CancerImmunologyVaccine Trial	2017	95
Combined MR Imaging of Oxygen Consumption and Supply Reveals Tumor Hypoxia and Aggressiveness in Prostate Cancer Patients Tord Hompland, Knut Håkon Hole, Harald Bull Ragnum, Cancer Research	2018	94
Pharmacokinetic parameters derived from dynamic contrast enhanced MRI of cervical cancers predict chemoradiotherapy outcome Erlend Andersen, Knut Håkon Hole, Kjersti V. Lund, Radiotherapy and Oncology Cervical CancerRadiation TherapyMedical ImagingMedicineDynamic Contrast	2013	77
Prediction of Response to Preoperative Chemoradiotherapy in Rectal Cancer by Multiplex Kinase Activity Profiling Sigurd Folkvord, Kjersti Flatmark, Svein Dueland, International Journal of Radiation OncologyBiologyPhysics MedicineColorectal CancerRectal CancerPreoperative ChemoradiotherapyCancer Genomics	2010	56
Diffusion-weighted magnetic resonance imaging of rectal cancer: tumour volume and perfusion fraction predict chemoradiotherapy response and survival Kine Mari Bakke, Knut Håkon Hole, Svein Dueland, Acta Oncologica	2017	48
Immunogenic cell death by neoadjuvant oxaliplatin and radiation protects against metastatic failure in high-risk rectal cancer Simer Jit Bains, Hanna Abrahamsson, Kjersti Flatmark, Cancer Immunology Immunotherapy	2019	46

Page 1